| ACC | Acetyl-CoA carboxylase |
| AES | Androgen excess society |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| BMI | Body mass index |
| COCs | Combined oral contraceptives |
| CVD | Cardiovascular disease |
| CYP17 | Cytochrome P450 family 17 |
| DHEAS | Dehydroepiandrosterone sulfate |
| DNL | De novo lipogenesis |
| FSH | Follicle-stimulating hormone |
| GGT | γ-Glutamyl transferase |
| GLUT | Glucose transport |
| GnRH | Gonadotropin-releasing hormone |
| HDL-C | High-density lipoprotein-cholesterol |
| HFD | High fat diet |
| HepG2 | Hepatoma cell |
| HNF-4α | Hepatocyte nuclear factor 4 α |
| HOMA-IR | Homeostatic model assessment for insulin resistance |
| IGT | Impaired glucose tolerance |
| IRS | Insulin receptor substrate |
| IL-1β | Interleukin-1β |
| IR | Insulin resistance |
| LDL | Low-density lipoprotein |
| LH | Luteinizing hormone |
| JNK | JNK c-Jun N-terminal kinase |
| MAPK | Mitogen-activated protein kinases |
| MEK-1/2 | Methyl ethyl ketone-1/2 |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| NEFAs | Non-esterified fatty acids |
| NF-kB | Nuclear factor-kB |
| NIH | National Institutes of Health |
| NR | Normal range |
| PCOS | Polycystic ovary syndrome |
| PCOM | Polycystic ovary morphology |
| PI3Kp85a | Phosphoinositide 3 kinase, p85 α |
| PPAR-γ | Peroxisome proliferator-activated receptor-γ |
| SHBG | Sex hormone-binding globulin |
| SREBP-1c | Sterol regulatory element binding protein 1c |
| T2DM | Type 2 diabetes mellitus |
| TNF-α | Tumor necrosis factor-α |